The present application includes purine compounds of Formula I or II: or apharmaceutically acceptable salt,solvate, and/or ester thereof, compositions containing such compounds,therapeutic methods that include the administration of suchcompounds, and therapeutic methods that include the administration of suchcompounds with at least one additional active agent.Said compounds are used as modulators of Toll -like receptor 7.
